Citations

1. Banks-Randall BA, Ballard RA (2005). Bronchopulmonary dysplasia. In HW Taeusch et al., eds., Avery's Diseases of the Newborn, 8th ed., chap. 49, pp. 723–736. Philadelphia: Saunders.

2. Yeh TF, et al. (2005). Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. New England Journal of Medicine, 350(13): 1304–1313.

3. Vaucher YE (2002). Bronchopulmonary dysplasia: An enduring challenge. Pediatrics in Review, 23(10): 349–357.

Other Works Consulted

• Ambalavanan N, et al. (2005). Vitamin A supplementation for extremely low birth weight infants: Outcome at 18 to 22 months. Pediatrics, 115(3): e249–e254.

• American Academy of Pediatrics, Canadian Paediatric Society (2002). Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics, 109(2): 330–338.

• Johnson AH, et al. (2002). High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. New England Journal of Medicine, 347(9): 633–642.

• Lestrud S (2004). Bronchopulmonary dysplasia. In RE Behrman et al., eds., Nelson Textbook of Pediatrics, 17th ed., chap. 408, pp. 1466–1467. Philadelphia: Saunders.

• Thilo EH, Rosenberg AA (2007). The newborn infant. In WW Hay et al., eds., Current Pediatric Diagnosis and Treatment, 18th ed., chap. 1, pp. 1–64. New York: Lange Medical Books/McGraw-Hill.

• Watterburg KL, Perkett EA (2006). Bronchopulmonary dysplasia in the neonate. In FD Burg et al., eds., Current Pediatric Therapy, 18th ed., pp. 252–256. Philadelphia: Saunders Elsevier.